TRIVENI PMS — All Prescriptions & Medications — Page 9
Practice Code: G83026 | LONDON, SE18 5TE
Showing results 401-450 of 487
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Erythromycin | 17 | 2,164 | £638 | -50.9% ▼ |
| Mycophenolate mofetil | 17 | 2,000 | £228 | -58.0% ▼ |
| 17 | 161 | £158 | -47.5% ▼ | |
| 17 | 1,198 | £70 | -65.9% ▼ | |
| 17 | 573 | £1.8K | +33.1% ▲ | |
| Sennosides | 16 | 2,400 | £48 | -48.2% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 16 | 672 | £387 | +1.2% vs avg |
| Telmisartan | 16 | 532 | £170 | -72.4% ▼ |
| Repaglinide | 16 | 480 | £40 | -33.8% ▼ |
| Other compound vitamin/mineral formulation preparations | 16 | 3,286 | £1.4K | -50.1% ▼ |
| Tizanidine hydrochloride | 16 | 1,920 | £82 | -39.6% ▼ |
| 16 | 19 | £82 | +185.8% ▲ | |
| 16 | 480 | £1.8K | -28.3% ▼ | |
| 16 | 690 | £632 | -60.6% ▼ | |
| Lisdexamfetamine dimesylate | 15 | 448 | £1.3K | -87.4% ▼ |
| Tapentadol | 15 | 784 | £1.6K | -63.6% ▼ |
| Doxycycline monohydrate | 15 | 910 | £524 | +38.1% ▲ |
| Rifaximin | 15 | 840 | £3.9K | -44.1% ▼ |
| Etodolac | 15 | 430 | £212 | -45.8% ▼ |
| Brinzolamide and timolol | 15 | 75 | £102 | -60.3% ▼ |
| 15 | 375 | £88 | -55.1% ▼ | |
| 15 | 200 | £495 | -26.8% ▼ | |
| Glycerol | 14 | 240 | £38 | -60.1% ▼ |
| Linaclotide | 14 | 392 | £500 | -23.4% ▼ |
| Isosorbide dinitrate | 14 | 784 | £231 | -22.1% ▼ |
| Aclidinium bromide/formoterol | 14 | 14 | £432 | -60.2% ▼ |
| Clomipramine hydrochloride | 14 | 1,848 | £469 | -66.8% ▼ |
| Hyoscine | 14 | 140 | £901 | +101.7% ▲ |
| Ropinirole hydrochloride | 14 | 740 | £146 | -86.8% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 14 | 1,400 | £92 | -90.7% ▼ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 14 | 99.0K | £2.2K | +12.9% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 14 | 2,100 | £339 | -47.3% ▼ |
| Metronidazole | 14 | 585 | £223 | -62.7% ▼ |
| 14 | 150 | £17 | -62.8% ▼ | |
| 14 | 420 | £523 | +122.1% ▲ | |
| 14 | 210 | £182 | -81.9% ▼ | |
| Celiprolol hydrochloride | 13 | 544 | £351 | -1.7% vs avg |
| Perindopril arginine with diuretic | 13 | 390 | £118 | -0.9% vs avg |
| Desloratadine | 13 | 450 | £37 | -54.9% ▼ |
| Levocetirizine | 13 | 390 | £50 | -16.6% ▼ |
| Temazepam | 13 | 91 | £81 | -77.3% ▼ |
| Chlorpromazine hydrochloride | 13 | 91 | £75 | -66.9% ▼ |
| Glimepiride | 13 | 390 | £10 | -85.9% ▼ |
| Ryeqo | 13 | 364 | £889 | +130.9% ▲ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 13 | 364 | £1.3K | +30.9% ▲ |
| Powder extensively hydrolysed formula (0913101) | 13 | 31.2K | £857 | -82.0% ▼ |
| Febuxostat | 13 | 364 | £28 | -65.2% ▼ |
| Loteprednol etabonate | 13 | 130 | £136 | +40.6% ▲ |
| Ketorolac trometamol | 13 | 85 | £65 | +40.1% ▲ |
| Emulsifying wax | 13 | 6,500 | £47 | +6.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.